Home » Events » Myeloproliferative Neoplasms Advances Day for Clinicians and Researchers
Date: | 17/11/2017 |
The programme is designed to combine high calibre lectures and interactive discussions to provide an educational opportunity to update clinicians in current issues within the management of Myeloproliferative Neoplasms. Suitable for Consultants, Trainees, Nurses, Pharmacists and Scientists working in Haematology.
● Prognosis in MPN
● Novel molecular tests
● Stroke and TIA in MPN
● Novel data regarding pathogenesis of MPN
● Aetiology of thrombosis and prevention in MPN
● SVT- what the haematologists need to know
● Use of novel anticoagulants in MPN or difficult scenarios
● Fertility, pregnancy, IVF
● BCSH Guideline for Eosinophilia
● Systemic mastocytosis
● CMML
● Treatment free remission in CML
● Novel agents for MPN
● Myelofibrosis
Professor Claire Harrison, Guy’s and St Thomas’, London
Professor Alessandro Vannucchi, University of Florence, Italy
Professor Tiziano Barbui, Bergamo, Italy
Professor Steffen Koschmeider, Aachen, Germany
Professor Tony Green, Cambridge University
Professor Martin Ellis, Tel Aviv, Israel
Dr Nauman Butt, Royal Liverpool University Hospital
Professor Eric Solary, Institut de Cancerologie Gustave Roussy, Paris
Professor Richard Clarke, University of Liverpool
Professor Ruben Mesa, UT San Antonio Cancer Centre, TX, USA
Professor Francisco Cervantes, Barcelona, Spain
Professor David Patch, Royal Free Hospital, London
Dr Deepti Radia, Guy’s and St Thomas’ Hospital, London
Dr Angela Hamblin, Oxford Molecular Diagnosis Centre
Professor Hannah Cohen, UCLH, London
Dr Susan Robinson, Guy’s and St Thomas’ Hospital, London
Dr Adam Mead, University of Oxford
Registration fees:
Consultants £108 (inc. VAT)
Trainees & other health professionals £90 (inc. VAT)
5 CPD approved
For more information please contact sandra@hartleytaylor.co.uk